The flavivirus capsid protein: Structure, function and perspectives towards drug design

Virus Research

Volumn 227, Issue , 2017, Pages 115-123

  Oliveira, Edson R A ^a   Mohana Borges, Ronaldo ^a   de Alencastro, Ricardo B ^a   Horta, Bruno A C ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antiviral; Capsid protein; Drug design; Flavivirus; Review

Indexed keywords

ANTIVIRUS AGENT; CAPSID PROTEIN;

DRUG DESIGN; FLAVIVIRUS; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; FLAVIVIRUS INFECTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CAPSID PROTEINS; DRUG DESIGN; DRUG DISCOVERY; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

EID: 84993869047     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2016.10.005     Document Type: Review

References (169)

1. Acosta, E.G., Castilla, V., Damonte, E.B., Infectious dengue-1 virus entry into mosquito C6/36 cells. Virus Res. 160:1–2 (2011), 173–179.
2. Alen, M.M., Schols, D., Dengue virus entry as target for antiviral therapy. J. Trop. Med., 2012, 2012, 628475.
3. Amberg, S.M., Rice, C.M., Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing. J. Virol. 73:10 (1999), 8083–8094.
4. Amberg, S.M., Nestorowicz, A., McCourt, D.W., Rice, C.M., NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies. J. Virol. 68:6 (1994), 3794–3802.
5. Araujo, A.Q., Silva, M.T., Araujo, A.P., Zika virus-associated neurological disorders: a review. Brain 139:Pt 8 (2016), 2122–2130.
6. Balinsky, C.A., Schmeisser, H., Ganesan, S., Singh, K., Pierson, T.C., Zoon, K.C., Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles. J. Virol. 87:24 (2013), 13094–13106.
7. Barrows, N.J., Campos, R.K., Powell, S.T., Prasanth, K.R., Schott-Lerner, G., Soto-Acosta, R., Galarza-Muñoz, G., McGrath, E.L., Urrabaz-Garza, R., Gao, J., Wu, P., Menon, R., Saade, G., Fernandez-Salas, I., Rossi, S.L., Vasilakis, N., Routh, A., Bradrick, S.S., Garcia-Blanco, M.A., A screen of FDA-Approved drugs for inhibitors of zika virus infection. Cell Host Microbe 20:2 (2016), 259–270.
8. Beesetti, H., Khanna, N., Swaminathan, S., Investigational drugs in early development for treating dengue infection. Expert Opin. Investig. Drugs 24:June (2016), 1–11 (in press).
9. Bhatt, S., Gething, P.W., Brady, O.J., Messina, J.P., Farlow, A.W., Moyes, C.L., Drake, J.M., Brownstein, J.S., Hoen, A.G., Sankoh, O., Myers, M.F., George, D.B., Jaenisch, T., Wint, G.R., Simmons, C.P., Scott, T.W., Farrar, J.J., Hay, S.I., The global distribution and burden of dengue. Nature 496:7446 (2013), 504–507.
10. Bhuvanakantham, R., Chong, M.K., Ng, M.L., Specific interaction of capsid protein and importin-alpha/beta influences West Nile virus production. Biochem. Biophys. Res. Commun. 389:1 (2009), 63–69.
11. Biedrzycka, A., Cauchi, M.R., Bartholomeusz, A., Gorman, J.J., Wright, P.J., Characterization of protease cleavage sites involved in the formation of the envelope glycoprotein and three non-structural proteins of dengue virus type 2, New Guinea C strain. J. Gen. Virol. 68:Pt 5 (1987), 1317–1326.
12. Bodenreider, C., Beer, D., Keller, T.H., Sonntag, S., Wen, D., Yap, L., Yau, Y.H., Shochat, S.G., Huang, D., Zhou, T., Caflisch, A., Su, X.C., Ozawa, K., Otting, G., Vasudevan, S.G., Lescar, J., Lim, S.P., A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease. Anal. Biochem. 395:2 (2009), 195–204.
13. Bogoch, I.I., Brady, O.J., Kraemer, M.U., German, M., Creatore, M.I., Kulkarni, M.A., Brownstein, J.S., Mekaru, S.R., Hay, S.I., Groot, E., Watts, A., Khan, K., Anticipating the international spread of Zika virus from Brazil. Lancet 387:10016 (2016), 335–336.
14. Bose, S., Basu, M., Banerjee, A.K., Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J. Virol. 78:15 (2004), 8146–8158.
15. Bulich, R., Aaskov, J.G., Nuclear localization of dengue 2 virus core protein detected with monoclonal antibodies. J. Gen. Virol. 73:Pt 11 (1992), 2999–3003.
16. Butler, D., Fears rise over yellow fever's next move. Nature 532:7598 (2016), 155–156.
17. Byk, L.A., Iglesias, N.G., De Maio, F.A., Gebhard, L.G., Rossi, M., Gamarnik, A.V., Dengue virus genome uncoating requires ubiquitination. mBio, 7(3), 2016 pii:e00804–16.
18. Byrd, C.M., Grosenbach, D.W., Berhanu, A., Dai, D., Jones, K.F., Cardwell, K.B., Schneider, C., Yang, G., Tyavanagimatt, S., Harver, C., Wineinger, K.A., Page, J., Stavale, E., Stone, M.A., Fuller, K.P., Lovejoy, C., Leeds, J.M., Hruby, D.E., Jordan, R., Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase. Antimicrob. Agents Chemother. 57:4 (2013), 1902–1912.
19. Byrd, C.M., Dai, D., Grosenbach, D.W., Berhanu, A., Jones, K.F., Cardwell, K.B., Schneider, C., Wineinger, K.A., Page, J.M., Harver, C., Stavale, E., Tyavanagimatt, S., Stone, M.A., Bartenschlager, R., Scaturro, P., Hruby, D.E., Jordan, R., A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrob. Agents Chemother. 57:1 (2013), 15–25.
20. Campbell, G.L., Hills, S.L., Fischer, M., Jacobson, J.A., Hoke, C.H., Hombach, J.M., Marfin, A.A., Solomon, T., Tsai, T.F., Tsu, V.D., Ginsburg, A.S., Estimated global incidence of Japanese encephalitis: a systematic review. Bull. World Health Organ. 89:10 (2011), 766–774 774A-774E.
21. Carvalho, F.A., Carneiro, F.A., Martins, I.C., Assunção-Miranda, I., Faustino, A.F., Pereira, R.M., Bozza, P.T., Castanho, M.A., Mohana-Borges, R., Da Poian, A.T., Santos, N.C., Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins. J. Virol. 86:4 (2012), 2096–2108.
22. Castro, J.E., Vado-Solis, I., Perez-Osorio, C., Fredeking, T.M., Modulation of cytokine and cytokine receptor/antagonist by treatment with doxycycline and tetracycline in patients with dengue fever. Clin. Dev. Immunol., 2011, 2011, 370872.
23. Chambers, T.J., Weir, R.C., Grakoui, A., McCourt, D.W., Bazan, J.F., Fletterick, R.J., Rice, C.M., Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc. Natl. Acad. Sci. U. S. A. 87:22 (1990), 8898–8902.
24. Chambers, T.J., Grakoui, A., Rice, C.M., Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites. J. Virol. 65:November (11) (1991), 6042–6050.
25. Chang, C.J., Luh, H.W., Wang, S.H., Lin, H.J., Lee, S.C., Hu, S.T., The heterogeneous nuclear ribonucleoprotein K (hnRNPK) interacts with dengue virus core protein. DNA Cell Biol. 20:9 (2001), 569–577.
26. Clyde, K., Harris, E., RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J. Virol. 80:5 (2006), 2170–2182.
27. Clyde, K., Barrera, J., Harris, E., The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis. Virology 379:2 (2008), 314–323.
28. Colpitts, T.M., Barthel, S., Wang, P., Fikrig, E., Dengue virus capsid protein binds core histones and inhibits nucleosome formation in human liver cells. PLoS One, 6(9), 2011, e24365.
29. Cregar-Hernandez, L., Jiao, G.S., Johnson, A.T., Lehrer, A.T., Wong, T.A., Margosiak, S.A., Small molecule pan-dengue and West Nile virus NS3 protease inhibitors. Antivir. Chem. Chemother. 21:5 (2011), 209–217.
30. Cronican, J.J., Thompson, D.B., Beier, K.T., McNaughton, B.R., Cepko, C.L., Liu, D.R., Potent delivery of functional proteins into Mammalian cells in vitro and in vivo using a supercharged protein. ACS Chem. Biol. 5:8 (2010), 747–752.
31. Dokland, T., Walsh, M., Mackenzie, J.M., Khromykh, A.A., Ee, K.H., Wang, S., West Nile virus core protein; tetramer structure and ribbon formation. Structure 12:7 (2004), 1157–1163.
32. Durbin, A.P., A dengue vaccine. Cell, 166(1), 2016 1–1.
33. Elachola, H., Gozzer, E., Zhuo, J., Memish, Z.A., A crucial time for public health preparedness: Zika virus and the 2016 Olympics, Umrah, and Hajj. Lancet 387:10019 (2016), 630–632.
34. Fajardo-Sánchez, E., Galiano, V., Villalaín, J., Molecular dynamics study of the membrane interaction of a membranotropic dengue virus C protein-derived peptide. J. Biomol. Struct. Dyn. 21 (2016), 1–12.
35. Falgout, B., Chanock, R., Lai, C.J., Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J. Virol. 63:5 (1989), 1852–1860.
36. Falgout, B., Pethel, M., Zhang, Y.M., Lai, C.J., Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J. Virol. 65:5 (1991), 2467–2475.
37. Faria, N.R., Azevedo Rdo, S., Kraemer, M.U., Souza, R., Cunha, M.S., Hill, S.C., Thézé, J., Bonsall, M.B., Bowden, T.A., Rissanen, I., Rocco, I.M., Nogueira, J.S., Maeda, A.Y., Vasami, F.G., Macedo, F.L., Suzuki, A., Rodrigues, S.G., Cruz, A.C., Nunes, B.T., Medeiros, D.B., Rodrigues, D.S., Nunes Queiroz, A.L., da Silva, E.V., Henriques, D.F., Travassos da Rosa, E.S., de Oliveira, C.S., Martins, L.C., Vasconcelos, H.B., Casseb, L.M., Simith Dde, B., Messina, J.P., Abade, L., Lourenço, J., Carlos Junior Alcantara, L., de Lima, M.M., Giovanetti, M., Hay, S.I., de Oliveira, R.S., Lemos Pda, S., de Oliveira, L.F., de Lima, C.P., da Silva, S.P., de Vasconcelos, J.M., Franco, L., Cardoso, J.F., Vianez-Júnior, J.L., Mir, D., Bello, G., Delatorre, E., Khan, K., Creatore, M., Coelho, G.E., de Oliveira, W.K., Tesh, R., Pybus, O.G., Nunes, M.R., Vasconcelos, P.F., Zika virus in the Americas: early epidemiological and genetic findings. Science 352:6283 (2016), 345–349.
38. Fassati, A., Multiple roles of the capsid protein in the early steps of HIV-1 infection. Virus Res. 170:1-2 (2012), 15–24.
39. Ferlenghi, I., Clarke, M., Ruttan, T., Allison, S.L., Schalich, J., Heinz, F.X., Harrison, S.C., Rey, F.A., Fuller, S.D., Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol. Cell 7:3 (2001), 593–602.
40. Freire, J.M., Veiga, A.S., Conceição, T.M., Kowalczyk, W., Mohana-Borges, R., Andreu, D., Santos, N.C., Da Poian, A.T., Castanho, M.A., Intracellular nucleic acid delivery by the supercharged dengue virus capsid protein. PLoS One, 8(12), 2013, e81450.
41. Freire, J.M., Veiga, A.S., de la Torre, B.G., Santos, N.C., Andreu, D., Da Poian, A.T., Castanho, M.A., Peptides as models for the structure and function of viral capsid proteins: insights on dengue virus capsid. Biopolymers 100:4 (2013), 325–336.
42. Freire, J.M., Santos, N.C., Veiga, A.S., Da Poian, A.T., Castanho, M.A., Rethinking the capsid proteins of enveloped viruses: multifunctionality from genome packaging to genome transfection. FEBS J. 282:12 (2015), 2267–2278.
43. Garcez, P.P., Loiola, E.C., Madeiro da Costa, R., Higa, L.M., Trindade, P., Delvecchio, R., Nascimento, J.M., Brindeiro, R., Tanuri, A., Rehen, S.K., Zika virus impairs growth in human neurospheres and brain organoids. Science 352:6287 (2016), 816–818.
44. Gubler, D.J., Kuno, G., Markoff, L., Flaviviruses. Knipe, D.M., Howley, P.M., (eds.) Fields Virology, 5th ed., 2007, Lippincott Williams and Wilkins, Philadelphia, PA, USA, 1153–1252.
45. Guzman, M.G., Harris, E., Dengue. Lancet 385:9966 (2015), 453–465.
46. Harrison, S.C., Viral membrane fusion. Nat. Struct. Mol. Biol. 15:7 (2008), 690–698.
47. Hayakawa, M., Umeyama, H., Iwadate, M., Tanahashi, T., Yano, Y., Enomoto, M., Tamori, A., Kawada, N., Murakami, Y., Development of novel hepatitis B virus capsid inhibitor using in silico screening. Biochem. Biophys. Res. Commun. 463:4 (2015), 1165–1175.
48. Heinz, F.X., Stiasny, K., Püschner-Auer, G., Holzmann, H., Allison, S.L., Mandl, C.W., Kunz, C., Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology 198:January (1) (1994), 109–117.
49. Ho, J.Y., Chern, J.H., Hsieh, C.F., Liu, S.T., Liu, C.J., Wang, Y.S., Kuo, T.W., Hsu, S.J., Yeh, T.K., Shih, S.R., Hsieh, P.W., Chiu, C.H., Horng, J.T., In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71. J. Antimicrob. Chemother. 71:7 (2016), 1922–1932.
50. Hovanessian, A.G., Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin. Cell Res. 16:2 (2006), 174–181.
51. Iglesias, N.G., Mondotte, J.A., Byk, L.A., De Maio, F.A., Samsa, M.M., Alvarez, C., Gamarnik, A.V., Dengue virus uses a non-Canonical function of the host GBF1-Arf-COPI system for capsid protein accumulation on lipid droplets. Traffic 16:9 (2015), 962–977.
52. Jones, C.T., Ma, L., Burgner, J.W., Groesch, T.D., Post, C.B., Kuhn, R.J., Flavivirus capsid is a dimeric alpha-helical protein. J. Virol. 77:12 (2003), 7143–7149.
53. Kaiser, R., Tick-borne encephalitis – still a serious disease?. Wien. Med. Wochenschr. 162 (2012), 11–12 229.
54. Kaiser, R., Tick-borne encephalitis. Nervenarzt 87:6 (2016), 667–680.
55. Kampmann, T., Yennamalli, R., Campbell, P., Stoermer, M.J., Fairlie, D.P., Kobe, B., Young, P.R., In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Antiviral Res. 84:3 (2009), 234–241.
56. Kielian, M., Rey, F.A., Virus membrane-fusion proteins: more than one way to make a hairpin. Nat. Rev. Microbiol. 4:1 (2006), 67–76.
57. Kiermayr, S., Kofler, R.M., Mandl, C.W., Messner, P., Heinz, F.X., Isolation of capsid protein dimers from the tick-borne encephalitis flavivirus and in vitro assembly of capsid-like particles. J. Virol. 78:15 (2004), 8078–8084.
58. Klumpp, K., Crépin, T., Capsid proteins of enveloped viruses as antiviral drug targets. Curr. Opin. Virol. 5 (2014), 63–71.
59. Kofler, R.M., Heinz, F.X., Mandl, C.W., Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence. J. Virol. 76:7 (2002), 3534–3543.
60. Kok, W.M., New developments in flavivirus drug discovery. Expert Opin. Drug Discov. 11:5 (2016 May), 433–445.
61. Kuhn, R.J., Zhang, W., Rossmann, M.G., Pletnev, S.V., Corver, J., Lenches, E., Jones, C.T., Mukhopadhyay, S., Chipman, P.R., Strauss, E.G., Baker, T.S., Strauss, J.H., Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:5 (2002), 717–725.
62. Kunze, U., Is there a need for a travel vaccination against tick-borne encephalitis?. Travel Med. Infect. Dis. 6:6 (2008), 380–383.
63. Kunze, U., The international scientific working group on tick-Borne encephalitis (ISW TBE): review of 17 years of activity and commitment. Ticks Tick Borne Dis. 7:3 (2016), 399–404.
64. Larocca, R.A., Abbink, P., Peron, J.P., Zanotto, P.M., Iampietro, M.J., Badamchi-Zadeh, A., Boyd, M., Ng'ang’a, D., Kirilova, M., Nityanandam, R., Mercado, N.B., Li, Z., Moseley, E.T., Bricault, C.A., Borducchi, E.N., Giglio, P.B., Jetton, D., Neubauer, G., Nkolola, J.P., Maxfield, L.F., Barrera, R.A., Jarman, R.G., Eckels, K.H., Michael, N.L., Thomas, S.J., Barouch, D.H., Vaccine protection against Zika virus from Brazil. Nature, 2016 (in press).
65. Lessler, J., Chaisson, L.H., Kucirka, L.M., Bi, Q., Grantz, K., Salje, H., Carcelen, A.C., Ott, C.T., Sheffield, J.S., Ferguson, N.M., Cummings, D.A., Metcalf, C.J., Rodriguez-Barraquer, I., Assessing the global threat from Zika virus. Science, 2016 pii: aaf8160.
66. Li, L., Lok, S.M., Yu, I.M., Zhang, Y., Kuhn, R.J., Chen, J., Rossmann, M.G., The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319:5871 (2008), 1830–1834.
67. Li, J., Huang, R., Liao, W., Chen, Z., Zhang, S., Huang, R., Dengue virus utilizes calcium modulating cyclophilin-binding ligand to subvert apoptosis. Biochem. Biophys. Res. Commun. 418:4 (2012), 622–627.
68. Lim, S.P., Sonntag, L.S., Noble, C., Nilar, S.H., Ng, R.H., Zou, G., Monaghan, P., Chung, K.Y., Dong, H., Liu, B., Bodenreider, C., Lee, G., Ding, M., Chan, W.L., Wang, G., Jian, Y.L., Chao, A.T., Lescar, J., Yin, Z., Vedananda, T.R., Keller, T.H., Shi, P.Y., Small molecule inhibitors that selectively block dengue virus methyltransferase. J. Biol. Chem. 286:8 (2011), 6233–6240.
69. Limjindaporn, T., Netsawang, J., Noisakran, S., Thiemmeca, S., Wongwiwat, W., Sudsaward, S., Avirutnan, P., Puttikhunt, C., Kasinrerk, W., Sriburi, R., Sittisombut, N., Yenchitsomanus, P.T., Malasit, P., Sensitization to Fas-mediated apoptosis by dengue virus capsid protein. Biochem. Biophys. Res. Commun. 362:2 (2007), 334–339.
70. Lindenbach, B.D., Rice, C.M., Molecular biology of flaviviruses. Adv. Virus Res. 59 (2003), 23–61.
71. Lo, S.J., Lee, C.C., Lai, H.J., The nucleolus: reviewing oldies to have new understandings. Cell Res. 16:6 (2006), 530–538.
72. Lorenz, I.C., Kartenbeck, J., Mezzacasa, A., Allison, S.L., Heinz, F.X., Helenius, A., Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J. Virol. 77:7 (2003), 4370–4382.
73. Lowe, R., Understanding the relative importance of global dengue risk factors. Trans. R. Soc. Trop. Med. Hyg. 109:10 (2015), 607–608.
74. Lucey, D., Gostin, L.O., Yellow fever epidemic: a new global health emergency?. JAMA 315:24 (2016), 2661–2662.
75. Ma, L., Jones, C.T., Groesch, T.D., Kuhn, R.J., Post, C.B., Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl. Acad. Sci. U. S. A. 101:10 (2004), 3414–3419.
76. Makarov, V.A., Braun, H., Richter, M., Riabova, O.B., Kirchmair, J., Kazakova, E.S., Seidel, N., Wutzler, P., Schmidtke, M., Pyrazolopyrimidines: potent inhibitors targeting the capsid of rhino- and enteroviruses. ChemMedChem 10:10 (2015), 1629–1634.
77. Makino, Y., Tadano, M., Anzai, T., Ma, S.P., Yasuda, S., Fukunaga, T., Detection of dengue 4 virus core protein in the nucleus II. Antibody against dengue 4 core protein produced by a recombinant baculovirus reacts with the antigen in the nucleus. J. Gen. Virol. 70:Pt 6 (1989), 1417–1425.
78. Malkki, H., CNS infections: Zika virus infection could trigger Guillain-Barré syndrome. Nat. Rev. Neurol., 12(4), 2016, 187.
79. Mandl, C.W., Flavivirus immunization with capsid-deletion mutants: basics, benefits, and barriers. Viral Immunol. 17:4 (2004), 461–472.
80. Markoff, L., Chang, A., Falgout, B., Processing of flavivirus structural glycoproteins: stable membrane insertion of premembrane requires the envelope signal peptide. Virology 204:November (2) (1994), 526–540.
81. Markoff, L., Falgout, B., Chang, A., A conserved internal hydrophobic domain mediates the stable membrane integration of the dengue virus capsid protein. Virology 233:1 (1997), 105–117.
82. Martins, I.C., Gomes-Neto, F., Faustino, A.F., Carvalho, F.A., Carneiro, F.A., Bozza, P.T., Mohana-Borges, R., Castanho, M.A., Almeida, F.C., Santos, N.C., Da Poian, A.T., The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif. Biochem. J. 444:3 (2012), 405–415.
83. Mastrangelo, E., Pezzullo, M., De Burghgraeve, T., Kaptein, S., Pastorino, B., Dallmeier, K., de Lamballerie, X., Neyts, J., Hanson, A.M., Frick, D.N., Bolognesi, M., Milani, M., Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J. Antimicrob. Chemother. 67:8 (2012), 1884–1894.
84. McNaughton, B.R., Cronican, J.J., Thompson, D.B., Liu, D.R., Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins. Proc. Natl. Acad. Sci. U. S. A. 106:15 (2009), 6111–6116.
85. Modis, Y., Ogata, S., Clements, D., Harrison, S.C., A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 100:12 (2003), 6986–6991.
86. Mongelard, F., Bouvet, P., Nucleolin: a multiFACeTed protein. Trends Cell Biol. 17:2 (2007), 80–86.
87. Mori, Y., Okabayashi, T., Yamashita, T., Zhao, Z., Wakita, T., Yasui, K., Hasebe, F., Tadano, M., Konishi, E., Moriishi, K., Matsuura, Y., Nuclear localization of Japanese encephalitis virus core protein enhances viral replication. J. Virol. 79:6 (2005), 3448–3458.
88. Mori, Y., Yamashita, T., Tanaka, Y., Tsuda, Y., Abe, T., Moriishi, K., Matsuura, Y., Processing of capsid protein by cathepsin L plays a crucial role in replication of Japanese encephalitis virus in neural and macrophage cells. J. Virol. 81:16 (2007), 8477–8487.
89. Mosso, C., Galván-Mendoza, I.J., Ludert, J.E., del Angel, R.M., Endocytic pathway followed by dengue virus to infect the mosquito cell line C6/36 HT. Virology 378:1 (2008), 193–199.
90. Mukhopadhyay, S., Kuhn, R.J., Rossmann, M.G., A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3:1 (2005), 13–22.
91. Nayak, V., Dessau, M., Kucera, K., Anthony, K., Ledizet, M., Modis, Y., Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J. Virol. 83:9 (2009), 4338–4344.
92. Nemésio, H., Palomares-Jerez, M.F., Villalaín, J., Hydrophobic segment of dengue virus C protein: interaction with model membranes. Mol. Membr. Biol. 30:4 (2013), 273–287.
93. Netsawang, J., Noisakran, S., Puttikhunt, C., Kasinrerk, W., Wongwiwat, W., Malasit, P., Yenchitsomanus, P.T., Limjindaporn, T., Nuclear localization of dengue virus capsid protein is required for DAXX interaction and apoptosis. Virus Res. 147:2 (2010), 275–283.
94. Nguyen, N.M., Tran, C.N., Phung, L.K., Duong, K.T., Huynh Hle, A., Farrar, J., Nguyen, Q.T., Tran, H.T., Nguyen, C.V., Merson, L., Hoang, L.T., Hibberd, M.L., Aw, P.P., Wilm, A., Nagarajan, N., Nguyen, D.T., Pham, M.P., Nguyen, T.T., Javanbakht, H., Klumpp, K., Hammond, J., Petric, R., Wolbers, M., Nguyen, C.T., Simmons, C.P., A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J. Infect. Dis. 207:9 (2013), 1442–1450.
95. Ni, P., Cheng Kao, C., Non-encapsidation activities of the capsid proteins of positive-strand RNA viruses. Virology 446:1-2 (2013), 123–132.
96. Nisole, S., Krust, B., Callebaut, C., Guichard, G., Muller, S., Briand, J.P., Hovanessian, A.G., The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans. J. Biol. Chem. 274:39 (1999), 27875–27884.
97. Niyomrattanakit, P., Chen, Y.L., Dong, H., Yin, Z., Qing, M., Glickman, J.F., Lin, K., Mueller, D., Voshol, H., Lim, J.Y., Nilar, S., Keller, T.H., Shi, P.Y., Inhibition of dengue virus polymerase by blocking of the RNA tunnel. J. Virol. 84:11 (2010), 5678–5686.
98. Niyomrattanakit, P., Abas, S.N., Lim, C.C., Beer, D., Shi, P.Y., Chen, Y.L., A fluorescence-based alkaline phosphatase-coupled polymerase assay for identification of inhibitors of dengue virus RNA-dependent RNA polymerase. J. Biomol. Screen. 16:2 (2011), 201–210.
99. Noble, C.G., Chen, Y.L., Dong, H., Gu, F., Lim, S.P., Schul, W., Wang, Q.Y., Shi, P.Y., Strategies for development of Dengue virus inhibitors. Antiviral Res. 85:3 (2010), 450–462.
100. Noble, C.G., Lim, S.P., Chen, Y.L., Liew, C.W., Yap, L., Lescar, J., Shi, P.Y., Conformational flexibility of the Dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor. J. Virol. 87:9 (2013), 5291–5295.
101. Noda, M., Masrinoul, P., Punkum, C., Pipattanaboon, C., Ramasoota, P., Setthapramote, C., Sasaki, T., Sasayama, M., Yamashita, A., Kurosu, T., Ikuta, K., Okabayashi, T., Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes. Biologics 6 (2012), 409–416.
102. Nowak, T., Färber, P.M., Wengler, G., Wengler, G., Analyses of the terminal sequences of West Nile virus structural proteins and of the in vitro translation of these proteins allow the proposal of a complete scheme of the proteolytic cleavages involved in their synthesis. Virology 169:2 (1989), 365–376.
103. Oh, W.K., Song, J., Hsp70 functions as a negative regulator of West Nile virus capsid protein through direct interaction. Biochem. Biophys. Res. Commun. 347:4 (2006), 994–1000.
104. Oh, W., Yang, M.R., Lee, E.W., Park, K.M., Pyo, S., Yang, J.S., Lee, H.W., Song, J., Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein. J. Biol. Chem. 281:40 (2006), 30166–30174.
105. Patkar, C.G., Jones, C.T., Chang, Y.H., Warrier, R., Kuhn, R.J., Functional requirements of the yellow fever virus capsid protein. J. Virol. 81:June (12) (2007), 6471–6481 Erratum in: J Virol. 2007; 81 (24) 13944.
106. Perilla, J.R., Hadden, J.A., Goh, B.C., Mayne, C.G., Schulten, K., All-Atom molecular dynamics of virus capsids as drug targets. J. Phys. Chem Lett. 7:10 (2016), 1836–1844.
107. Petersen, E., Wilson, M.E., Touch, S., McCloskey, B., Mwaba, P., Bates, M., Dar, O., Mattes, F., Kidd, M., Ippolito, G., Azhar, E.I., Zumla, A., Rapid spread of zika virus in the americas – implications for public health preparedness for mass gatherings at the 2016 Brazil olympic games. Int. J. Infect. Dis. 44 (2016), 11–15.
108. Petersen, L.R., Jamieson, D.J., Powers, A.M., Honein, M.A., Zika virus. N. Engl. J. Med. 374:16 (2016), 1552–1563.
109. Piccini, L.E., Castilla, V., Damonte, E.B., Dengue-3 virus entry into vero cells: role of clathrin-Mediated endocytosis in the outcome of infection. PLoS One, 10(10), 2015, e0140824.
110. Poh, M.K., Yip, A., Zhang, S., Priestle, J.P., Ma, N.L., Smit, J.M., Wilschut, J., Shi, P.Y., Wenk, M.R., Schul, W., A small molecule fusion inhibitor of dengue virus. Antiviral Res. 84:3 (2009), 260–266.
111. Potisopon, S., Priet, S., Collet, A., Decroly, E., Canard, B., Selisko, B., The methyltransferase domain of dengue virus protein NS5 ensures efficient RNA synthesis initiation and elongation by the polymerase domain. Nucl. Acids Res., 44(6), 2016, 2974.
112. Preugschat, F., Yao, C.W., Strauss, J.H., In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3. J. Virol. 64:9 (1990), 4364–4374.
113. Randolph, V.B., Winkler, G., Stollar, V., Acidotropic amines inhibit proteolytic processing of flavivirus prM protein. Virology 174:2 (1990), 450–458.
114. Roby, J.A., Bielefeldt-Ohmann, H., Prow, N.A., Chang, D.C., Hall, R.A., Khromykh, A.A., Increased expression of capsid protein in trans enhances production of single-round infectious particles by West Nile virus DNA vaccine candidate. J. Gen. Virol. 95:Pt 10 (2014), 2176–2191.
115. Ruiz-Linares, A., Cahour, A., Després, P., Girard, M., Bouloy, M., Processing of yellow fever virus polyprotein: role of cellular proteases in maturation of the structural proteins. J. Virol. 63:10 (1989), 4199–4209.
116. Said, E.A., Courty, J., Svab, J., Delbé, J., Krust, B., Hovanessian, A.G., Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin. FEBS J. 272:18 (2005), 4646–4659.
117. Salgado, D., Zabaleta, T.E., Hatch, S., Vega, M.R., Rodriguez, J., Use of pentoxifylline in treatment of children with dengue hemorrhagic fever. Pediatr. Infect. Dis. J. 31:7 (2012), 771–773.
118. Samsa, M.M., Mondotte, J.A., Iglesias, N.G., Assunção-Miranda, I., Barbosa-Lima, G., Da Poian, A.T., Bozza, P.T., Gamarnik, A.V., Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog., 5(10), 2009, e1000632.
119. Samsa, M.M., Mondotte, J.A., Caramelo, J.J., Gamarnik, A.V., Uncoupling cis-Acting RNA elements from coding sequences revealed a requirement of the N-terminal region of dengue virus capsid protein in virus particle formation. J. Virol. 86:2 (2012), 1046–1058.
120. Scaturro, P., Trist, I.M., Paul, D., Kumar, A., Acosta, E.G., Byrd, C.M., Jordan, R., Brancale, A., Bartenschlager, R., Characterization of the mode of action of a potent dengue virus capsid inhibitor. J. Virol. 88:19 (2014), 11540–11555.
121. Schlick, P., Kofler, R.M., Schittl, B., Taucher, C., Nagy, E., Meinke, A., Mandl, C.W., Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations. Vaccine 28:36 (2010), 5903–5909.
122. Sejvar, J.J., West nile virus infection. Microbiol Spectr., 4(June (3)), 2016.
123. Smithburn, K., Hughes, T., Burke, A., Paul, J., A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. Hyg. 20 (1940), 471–472.
124. Soto-Acosta, R., Bautista-Carbajal, P., Syed, G.H., Siddiqui, A., Del Angel, R.M., Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus. Antiviral Res. 109 (2014), 132–140.
125. Speight, G., Coia, G., Parker, M.D., Westaway, E.G., Gene mapping and positive identification of the non-structural proteins NS2A, NS2B, NS3, NS4B and NS5 of the flavivirus Kunjin and their cleavage sites. J. Gen. Virol. 69:Pt 1 (1988), 23–34 PubMed PMID: 2826667.
126. Steffen, R., Epidemiology of tick-borne encephalitis (TBE) in international travellers to Western/Central Europe and conclusions on vaccination recommendations. J. Travel Med., 23(April (4)), 2016 pii: taw018.
127. Suksanpaisan, L., Susantad, T., Smith, D.R., Characterization of dengue virus entry into HepG2 cells. J. Biomed. Sci., 16, 2009, 17.
128. Tadano, M., Makino, Y., Fukunaga, T., Okuno, Y., Fukai, K., Detection of dengue 4 virus core protein in the nucleus I. A monoclonal antibody to dengue 4 virus reacts with the antigen in the nucleus and cytoplasm. J. Gen. Virol. 70:Pt 6 (1989), 1409–1415.
129. Tajrishi, M.M., Tuteja, R., Tuteja, N., Nucleolin: the most abundant multifunctional phosphoprotein of nucleolus. Commun. Integr. Biol. 4:3 (2011), 267–275.
130. Tam, D.T., Ngoc, T.V., Tien, N.T., Kieu, N.T., Thuy, T.T., Thanh, L.T., Tam, C.T., Truong, N.T., Dung, N.T., Qui, P.T., Hien, T.T., Farrar, J.J., Simmons, C.P., Wolbers, M., Wills, B.A., Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin. Infect. Dis. 55:9 (2012), 1216–1224.
131. Tayyari, F., Marchant, D., Moraes, T.J., Duan, W., Mastrangelo, P., Hegele, R.G., Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 17:9 (2011), 1132–1135.
132. Thenin-Houssier, S., de Vera, I.M., Pedro-Rosa, L., Brady, A., Richard, A., Konnick, B., Opp, S., Buffone, C., Fuhrmann, J., Kota, S., Billack, B., Pietka-Ottlik, M., Tellinghuisen, T., Choe, H., Spicer, T., Scampavia, L., Diaz-Griffero, F., Kojetin, D.J., Valente, S.T., Ebselen, a small-Molecule capsid inhibitor of HIV-1 replication. Antimicrob. Agents Chemother. 60:4 (2016), 2195–2208.
133. Thompson, D.B., Cronican, J.J., Liu, D.R., Engineering and identifying supercharged proteins for macromolecule delivery into mammalian cells. Methods Enzymol. 503 (2012), 293–319.
134. Thomas, S.J., Rothman, A.L., Trials and tribulations on the path to developing a dengue vaccine. Vaccine 33:Suppl. 4 (2015), D24–D31.
135. Thongtan, T., Wikan, N., Wintachai, P., Rattanarungsan, C., Srisomsap, C., Cheepsunthorn, P., Smith, D.R., Characterization of putative Japanese encephalitis virus receptor molecules on microglial cells. J. Med. Virol. 84:4 (2012), 615–623.
136. Tomlinson, S.M., Watowich, S.J., Anthracene-based inhibitors of dengue virus NS2B-NS3 protease. Antiviral Res. 89:2 (2011), 127–135.
137. Tomlinson, S.M., Watowich, S.J., Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors. Antiviral Res. 93:2 (2012), 245–252.
138. Tomlinson, S.M., Malmstrom, R.D., Russo, A., Mueller, N., Pang, Y.P., Watowich, S.J., Structure-based discovery of dengue virus protease inhibitors. Antiviral Res. 82:3 (2009), 110–114.
139. Tomlinson, S.M., Malmstrom, R.D., Watowich, S.J., New approaches to structure-based discovery of dengue protease inhibitors. Infect. Disord. Drug Targets 9:3 (2009), 327–343.
140. Tsuda, Y., Mori, Y., Abe, T., Yamashita, T., Okamoto, T., Ichimura, T., Moriishi, K., Matsuura, Y., Nucleolar protein B23 interacts with Japanese encephalitis virus core protein and participates in viral replication. Microbiol. Immunol. 50:3 (2006), 225–234.
141. Vasconcelos, P.F., Monath, T.P., Yellow fever remains a potential threat to public health. Vector Borne Zoonotic Dis. 16:August (8) (2016), 566–567.
142. Ventura, C.V., Maia, M., Bravo-Filho, V., Góis, A.L., Belfort, R. Jr., Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet, 387(10015), 2016, 228.
143. Verma, R., Khanna, P., Chawla, S., Yellow fever vaccine: an effective vaccine for travelers. Hum. Vaccin. Immunother. 10:1 (2014), 126–128.
144. Wang, H., Liang, G., Epidemiology of Japanese encephalitis: past, present, and future prospects. Ther. Clin. Risk Manag. 11 (2015), 435–448.
145. Wang, S.H., Syu, W.J., Huang, K.J., Lei, H.Y., Yao, C.W., King, C.C., Hu, S.T., Intracellular localization and determination of a nuclear localization signal of the core protein of dengue virus. J. Gen. Virol. 83:Pt 12 (2002), 3093–3102.
146. Wang, S.H., Syu, W.J., Hu, S.T., Identification of the homotypic interaction domain of the core protein of dengue virus type 2. J. Gen. Virol. 85:Pt 8 (2004), 2307–2314.
147. Wang, Q.Y., Patel, S.J., Vangrevelinghe, E., Xu, H.Y., Rao, R., Jaber, D., Schul, W., Gu, F., Heudi, O., Ma, N.L., Poh, M.K., Phong, W.Y., Keller, T.H., Jacoby, E., Vasudevan, S.G., A small-molecule dengue virus entry inhibitor. Antimicrob. Agents Chemother. 53:5 (2009), 1823–1831.
148. Watanabe, S., Rathore, A.P., Sung, C., Lu, F., Khoo, Y.M., Connolly, J., Low, J., Ooi, E.E., Lee, H.S., Vasudevan, S.G., Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial. Antiviral Res. 96:1 (2012), 32–35.
149. Watrin, L., Ghawché, F., Larre, P., Neau, J.P., Mathis, S., Fournier, E., Guillain-Barré syndrome (42 cases) occurring during a zika virus outbreak in French Polynesia. Medicine (Baltimore), 95(14), 2016, e3257.
150. Weaver, S.C., Costa, F., Garcia-Blanco, M.A., Ko, A.I., Ribeiro, G.S., Saade, G., Shi, P.Y., Vasilakis, N., Zika virus: history, emergence, biology, and prospects for control. Antiviral Res. 130 (2016), 69–80.
151. Westaway, E.G., Khromykh, A.A., Kenney, M.T., Mackenzie, J.M., Jones, M.K., Proteins C and NS4B of the flavivirus Kunjin translocate independently into the nucleus. Virology 234:1 (1997), 31–41.
152. Whitehorn, J., Van Vinh Chau, N., Truong, N.T., Tai, L.T., Van Hao, N., Hien, T.T., Wolbers, M., Merson, L., Dung, N.T., Peeling, R., Simmons, C., Wills, B., Farrar, J., Lovastatin for adult patients with dengue: protocol for a randomised controlled trial. Trials, 13, 2012, 203.
153. Whitehorn, J., Nguyen, C.V., Khanh, L.P., Kien, D.T., Quyen, N.T., Tran, N.T., Hang, N.T., Truong, N.T., Hue Tai, L.T., Cam Huong, N.T., Nhon, V.T., Van Tram, T., Farrar, J., Wolbers, M., Simmons, C.P., Wills, B., Lovastatin for the treatment of adult patients with dengue: a randomized, double-Blind, placebo-Controlled trial. Clin. Infect. Dis. 62:4 (2016), 468–476.
154. Wright, P.J., Cauchi, M.R., Ng, M.L., Definition of the carboxy termini of the three glycoproteins specified by dengue virus type 2. Virology 171:1 (1989), 61–67.
155. Xiao, X., Feng, Y., Zhu, Z., Dimitrov, D.S., Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem. Biophys. Res. Commun. 411:2 (2011), 253–258.
156. Yamshchikov, V.F., Compans, R.W., Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study. J. Virol. 68:9 (1994), 5765–5771.
157. Yamshchikov, V.F., Compans, R.W., Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease. J. Virol. 69:4 (1995), 1995–2003.
158. Yang, J.S., Ramanathan, M.P., Muthumani, K., Choo, A.Y., Jin, S.H., Yu, Q.C., Hwang, D.S., Choo, D.K., Lee, M.D., Dang, K., Tang, W., Kim, J.J., Weiner, D.B., Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway. Emerg. Infect. Dis. 8:December (12) (2003), 1379–1384 Erratum in: Emerg Infect Dis. 2003; 9(3) 406.
159. Yang, C.C., Hsieh, Y.C., Lee, S.J., Wu, S.H., Liao, C.L., Tsao, C.H., Chao, Y.S., Chern, J.H., Wu, C.P., Yueh, A., Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay. Antimicrob. Agents Chemother. 55:1 (2011), 229–238.
160. Yang, L., Wang, Y.J., Chen, H.J., Shi, L.P., Tong, X.K., Zhang, Y.M., Wang, G.F., Wang, W.L., Feng, C.L., He, P.L., Xu, Y.B., Lu, M.J., Tang, W., Nan, F.J., Zuo, J.P., Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation. Antiviral Res. 125 (2016), 25–33.
161. Yin, Z., Chen, Y.L., Schul, W., Wang, Q.Y., Gu, F., Duraiswamy, J., Kondreddi, R.R., Niyomrattanakit, P., Lakshminarayana, S.B., Goh, A., Xu, H.Y., Liu, W., Liu, B., Lim, J.Y., Ng, C.Y., Qing, M., Lim, C.C., Yip, A., Wang, G., Chan, W.L., Tan, H.P., Lin, K., Zhang, B., Zou, G., Bernard, K.A., Garrett, C., Beltz, K., Dong, M., Weaver, M., He, H., Pichota, A., Dartois, V., Keller, T.H., Shi, P.Y., An adenosine nucleoside inhibitor of dengue virus. Proc. Natl. Acad. Sci. U. S. A. 106:48 (2009), 20435–20439.
162. Yin, Z., Chen, Y.L., Kondreddi, R.R., Chan, W.L., Wang, G., Ng, R.H., Lim, J.Y., Lee, W.Y., Jeyaraj, D.A., Niyomrattanakit, P., Wen, D., Chao, A., Glickman, J.F., Voshol, H., Mueller, D., Spanka, C., Dressler, S., Nilar, S., Vasudevan, S.G., Shi, P.Y., Keller, T.H., N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymerase. J. Med. Chem. 52:24 (2009), 7934–7937.
163. Yu, I.M., Zhang, W., Holdaway, H.A., Li, L., Kostyuchenko, V.A., Chipman, P.R., Kuhn, R.J., Rossmann, M.G., Chen, J., Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319:5871 (2008), 1834–1837.
164. Yun, S.-I., Lee, Y.-M., Japanese encephalitis: the virus and vaccines. Hum. Vaccin. Immunother. 10:2 (2014), 263–279.
165. Zaitseva, E., Yang, S.T., Melikov, K., Pourmal, S., Chernomordik, L.V., Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathog., 6(10), 2010, e1001131.
166. Zhang, Y., Kaufmann, B., Chipman, P.R., Kuhn, R.J., Rossmann, M.G., Structure of immature west nile virus. J. Virol. 81:June (11) (2007), 6141–6145.
167. Zhou, Z., Khaliq, M., Suk, J.E., Patkar, C., Li, L., Kuhn, R.J., Post, C.B., Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. ACS Chem. Biol. 3:12 (2008), 765–775.
168. de Wispelaere, M., LaCroix, A.J., Yang, P.L., The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase. J. Virol. 87:13 (2013), 7367–7381.
169. van Cleef, K.W., Overheul, G.J., Thomassen, M.C., Kaptein, S.J., Davidson, A.D., Jacobs, M., Neyts, J., van Kuppeveld, F.J., van Rij, R.P., Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNAreplication. Antiviral Res. 99:2 (2013), 165–171.